inflamation 2012

45
 INFLAMA T ION Ph.D

Upload: eugeniu-sirbu

Post on 18-Feb-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 1/45

 INFLAMATION 

Ph.D

Page 2: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 2/45

Defnition

Infammation -  is the reaction o tissueand

  its microcirculation to a pathogenicinsult,

  aimed to localize and remove thealtered

 cells & harmul actor ollowed by 2

Page 3: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 3/45

Basic orms o inammation

• Acute exudative inflammation

• Chronic inflammation

• Chronic granulomatous inflammation

Page 4: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 4/45

Main eatures o acuteinammation

• local process

• genetically determined

• strictly sequentially

• positive influence on tissue

• usually has positive ending

Page 5: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 5/45

Biological signifcance oinammation

 

• to eliminate the pathogenic agent,

• to remove injured tissue’s components,

• to repair the tissue.

Page 6: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 6/45

Etiology

•Infections factors (toxins)•Trauma (lunt an! "enetrating)

•Physical and chemical agents

(urns or rostite# irra!iation#chemicals)

•Tissue necrosis (rom any cause)

•Foreign bodies (s"linters$ !irt$sutures)

•Immune reactions

( hy"ersensiti%ity)

Page 7: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 7/45

&"rea! o 'nammation

•ocal inammation is limite! tocircumscrie! area o tissue inthe %icinity o its "ort o entry.

•Metastatic inammation *transmission o theinammatory "athogens into

other organs an! tissues.•+enerali,e! inammation *"athogen s"rea!s !i-usely

throughout the entire o!y.

Page 8: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 8/45

 inammation

Page 9: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 9/45

he car!inal sym"toms o inammation/

•ruor (redness, hy"eremia)

•calor (local hy"erthermia$ e%er)•tumor (tissue swelling, inammatorytumor)

•!olor (urning "ain)

•lose o unction (unctionalim"airment)

  hese eatures corres"on! toinammatory e%ents ovasodilatation, edema, an! tissue

damage.

Page 10: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 10/45

Pathogenesis

The stages of inflammation

•Vascular stage (vasodilatation,

increasing o vascular permeability,

epression o vascular receptors!

•Cellular stage (phagocytosis, "#-

dependent cytotoicity!

•&tage o tissue reco%ery ($broplasia,

angiogenesis, cell division%tissue remodeling!

Page 11: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 11/45

Phases o acute inammation

  Primary alteration

  Secondary alteration

  Vascular changes (reactions)

Exudation and migration of

leucocytes in site of

inflammation

  Cellular proliferation and

tissue regeneration.

   V  a  s  c  u   l  a  r  s   t  a  g

  e

   C  e   l   l  u   l  a  r  s

   t  a  g  e

Page 12: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 12/45

Page 13: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 13/45

• The acute inflammatory response begins with direct

injury (alteration) or stimulation of cellular or structuralcomponents of a tissue, including:

• ndothelium

• Tissue macrophages and mast cells

• !eutrophils

• "latelets

• #esenchymal cells (e.g., fibroblasts)• "arenchymal cells

$ellular phase

Page 14: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 14/45

  Endothelial cells are %ey players of inflammation.

• "rovide selective permeability barrier (to e&ogenousand endogenous inflammatory stimuli)'

• egulate leu%ocyte migration (by e&pression of cell

adhesion molecules and receptors)'

• egulate modulate immune responses (by synthesis

release of inflammatory mediators)'

• egulate immune cell proliferation (by secretion of

hematopoietic colony*stimulating factors ($+s)).

- lt ti

Page 15: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 15/45

-. lteration 

primary alteration / is the result of tissue insult by the harmful factor, that

leads to activation of

secondary alteration via activation of 

soluble mediators and

recruitment of inflammatory cells (leucocytes) to the area of damage.

Page 16: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 16/45

 

0uring primary alteration macrophages

  and granulocytes mount phagocytic  responses (engulf and destroy bacteria).

  These are accompanied by the release of

mediators  and reactive o&ygen species

into adjacent tissues that may causetissue injury (secondary alteration).

Page 17: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 17/45

Primaryalteration

   S  e

  c  o  n   d  a  r  y  a   l   t  e  r  a   t   i  o  n

Page 18: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 18/45

+econdary alteration begins with releasing of

secondary endogenous mediators ofinflammation:

•1umoral mediators ($omplement sytem, 2inin

  sytem, $lotting sytem, ibrinolytic system).

•$ellular mediators (preformed, newly

  synthesi3ed (both from leu%ocytes).

 

# di t f i fl ti ( t d f d

Page 19: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 19/45

#ediators of inflammation (supported of secondary

alteration)

Page 20: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 20/45

$ellular (leu%ocyte) mediators

! "# !$$

Page 21: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 21/45

1 l di t

Page 22: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 22/45

1umoral mediators

(anaphyloto&ins)exudate

($lotting factor )

Page 23: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 23/45

Eff t f i fl t di t

Page 24: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 24/45

Effects of inflammatory mediators

%

Page 25: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 25/45

4ascular phase

The vascular changes in inflammation

involve the:• arterioles,

• capillaries,

• venules of microcirculatory bed.

These changes begin almost immediately after 

injury and are characteri3ed by vasodilation andchanges in blood flow followed by increased 

vascular permeability  and leakage of protein-rich

fluid (exudate) to e&travascular tissues.

Page 26: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 26/45

Capillary &ed changes in inflammation area

Page 27: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 27/45

he ty"es o increasing %ascular "ermeaility insite o inammation (&..0oins)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  P                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           e                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         r                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          m

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           e                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   l                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              y                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          m                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           e                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         s                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            u                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        r                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   i                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           n

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          g                                                                                                                                                                                                                                        

1 32   2 4 5 6 7

  time$ hours

8. Earlier (transiently)  ty"e o "ermeaility.

8

B. 'mme!iately (longer)ty"e o "ermeaility

B

C. Delaye! ty"e o"ermeility.

C

9

Page 28: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 28/45

dema is accumulation of fluid within the

e&travascular compartment and interstitial

tissues.

Edema

  Serous

  'i&rinous  Purulent

  Suppurative

  Serosagnuineous

Exudateransudate

Page 29: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 29/45

ransudate

• is edema fluid ith lo protein

content (specific gravity * ".+",- *

+.+$ mgml

Page 30: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 30/45

Exudate

• is edema fluid ith a high protein

concentration (specific gravity / ".+",)-

hich frequently contains inflammatorycells.

• Exudates are o&served early in acute

inflammatory reactions and are produced &ymild in0uries- such as sun&urn or traumatic

&listers.

Page 31: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 31/45

Types of e&udateype Serum Proteins Cells

+erous 5 albumins *

ibrous 5 albumins, fibrin *

"urulent 5 albumins, fibrin leu%ocytes, cell’sdebris

+ero *sangvinous 5 albumins, fibrin leu%ocytes,erythrocytes

Page 32: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 32/45

Cellular events1 leu2ocyte transmigration

in vascular lumen1

".marinating-

3.rolling-

$.adhesion to endothelium.through vascular all1

4. transmigration across the endothelium

  (diapedesis)

in the tissue1

,. migration to interstitial tissues toard a

  chemotactic stimulus.

Page 33: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 33/45

Page 34: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 34/45

Page 35: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 35/45

he type of emigrating leu2ocyte varies ith1

•Age

•nflammatory response•ype of stimulus.

n most forms of acute inflammation-

neutrophils predominate in the inflammatory

infiltrate during the first 5 to 34 hours- then

are replaced &y monocytes in 34 to 46 hours

Ph t i

Page 36: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 36/45

Phagocytosis

is responsi&le for eliminating the in0urious agents

(the ma0or &enefits derived from the accumulation of 

 leu2ocytes at the inflammatory focus).

Phagocytosis involves the folloing steps11. recognition and attachment  of the particle to &e

ingested &y the leu2ocyte7

3. its engulfment - ith su&sequent formation of aphagocytic vacuole7

3. killing  or degradation of the ingested material

Page 37: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 37/45

Page 38: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 38/45

Page 39: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 39/45

8ecognition 9 attachment to &acteria

acteria

leu:ocyte

21

: h tt 2 & t i

Page 40: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 40/45

:acrophages attac2 on &acteria

leu:ocyte

acteria

ca"illary

25

Page 41: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 41/45

;acteria digestion

leu:ocyte

acteria

lysosomes

"hagolysosomne

27

Page 42: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 42/45

Proliferative events in inflammation(&y <.;=c2er- >.?en2- Ph.@.>eit)

  * t+; ;+;  +;  * <; 

"rolieration angiogenesis

 macro"hage

frolast

5

ca"illaries

Page 43: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 43/45

Tissue recovery

Page 44: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 44/45

Tissue recovery

Page 45: INFLAMATION 2012

7/23/2019 INFLAMATION 2012

http://slidepdf.com/reader/full/inflamation-2012 45/45

han: you or

your attention